B, R., F, G., H, N., C, L. J., G, R., P, S., . . . P, G. (2026). Immunological efficacy and safety of influenza vaccination in adults with sarcoidosis: The SARCOVAC study. Vaccine, 86, 128732. https://doi.org/10.1016/j.vaccine.2026.128732
Chicago Style (17th ed.) CitationB, Ranque, et al. "Immunological Efficacy and Safety of Influenza Vaccination in Adults with Sarcoidosis: The SARCOVAC Study." Vaccine 86 (2026): 128732. https://doi.org/10.1016/j.vaccine.2026.128732.
MLA (9th ed.) CitationB, Ranque, et al. "Immunological Efficacy and Safety of Influenza Vaccination in Adults with Sarcoidosis: The SARCOVAC Study." Vaccine, vol. 86, 2026, p. 128732, https://doi.org/10.1016/j.vaccine.2026.128732.
Warning: These citations may not always be 100% accurate.